Skip to search formSkip to main contentSkip to account menu

TA 383

Known as: TA-383 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1997
1997
The novel anti-rheumatic drug TA-383 has a macrophage migration enhancing activity.
We have investigated the effect of a novel anti-rheumatic drug, cis-2-(4-chlorophenyl)-4,5-diphenyl-2-imidazoline hydrochloride… 
Highly Cited
1995
Highly Cited
1995
Effect of a novel anti-rheumatic drug, TA-383, on type II collagen-induced arthritis.
1993
1993
Effect of a novel anti-rheumatic drug, TA-383, on type II collagen-induced arthritis--suppressive effect of TA-383 on interleukin 6 production.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)